Marmet and Oxytocin Massage for Breast Milk Increase (RCT)

September 16, 2025 updated by: Aysima Yalçıntepe, Ege University

The Effectiveness of the Marmet Technique and Oxytocin Massage on Breast Milk Quantity in Mothers Who Have Undergone Cesarean Section

This study is designed as a randomized controlled single-blind experimental study to examine the effectiveness of the oxytocin massage and Marmet technique applied to mothers who have undergone cesarean section on breast milk quantity and maternal state anxiety levels. The hypotheses of the study are as follows:

H0.1. There is no difference in the amount of breast milk among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups.

H1.1. There is a difference in the amount of breast milk among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups.

H0.2. There is no difference in the state anxiety scale scores among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups.

H1.2. There is a difference in the state anxiety scale scores among mothers in the Marmet technique, oxytocin massage, and control (placebo) groups.

Participants:

Marmet technique, oxytocin massage, and control (placebo) groups will be informed about the study and asked to provide their consent. Participants will complete the descriptive questionnaire. Colostrum status will be checked and marked as "present" or "absent" on the "Breast Milk, Vital Signs, and Pain Level Form." Under researcher supervision, the mother will breastfeed her baby. Afterward, the State Anxiety Inventory will be administered.

Two hours later, mothers will express milk using a hospital-grade pump, with 15 minutes on each breast (total 30 minutes). Milk volume, vital signs, pain levels, and milk flow rate will be recorded on the relevant form. Following this, mothers in the Marmet group will receive 10 minutes of the Marmet technique, mothers in the oxytocin group will receive 5 minutes of oxytocin massage, and mothers in the control group will receive 5 minutes of light touch on their wrists and shoulders. Immediately after, milk expression will again be performed with 15 minutes per breast (30 minutes total). The State Anxiety Inventory will be re-administered, and milk amount, vital signs, pain levels, and flow rate will be recorded again.

All mothers will express milk using a hospital-grade breast pump, and the expression duration is standardized as 15 minutes per breast (30 minutes total) based on the literature. Two expressions will be performed - one before and one immediately after the intervention. Expressed milk will not be discarded and will instead be used to feed the babies via spoon or syringe under the researcher's supervision.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This randomized controlled, single-blind experimental study aims to explore the physiological and psychological outcomes of two non-pharmacological breast stimulation techniques-oxytocin massage and the Marmet technique-on mothers who have undergone cesarean delivery. Specifically, the study investigates their effects on breast milk volume and maternal state anxiety levels during the early postpartum period.

Breastfeeding challenges are more commonly observed following cesarean deliveries due to delayed lactogenesis II, postoperative pain, mother-infant separation, and increased maternal stress. Non-invasive breast stimulation methods, such as the Marmet technique (which includes a structured pattern of massage, compression, and milk expression by hand) and oxytocin massage (which involves light tactile stimulation of the upper back and shoulders to promote oxytocin release), may provide physiological and psychological benefits to these mothers. This study systematically evaluates the efficacy of these techniques within a controlled hospital setting using standardized procedures.

Breast milk expression will be standardized using a hospital-grade electric pump, with a fixed pumping duration of 15 minutes per breast. Milk volume will be measured using calibrated collection containers provided with the pump. Vital signs (e.g., heart rate, blood pressure), self-reported pain levels (via Visual Analog Scale), and observed milk flow rate (rated as slow, moderate, or fast) will be recorded at each session.

Psychological impact will be assessed using the State-Trait Anxiety Inventory (STAI), focusing on the state anxiety subscale. This tool is a validated measure to assess transient anxiety responses under stress or in new environments, such as hospitalization or breastfeeding initiation after surgery.

The oxytocin massage protocol consists of light, rhythmic touch applied to the mother's upper arms, shoulders, and back for 5 minutes, aiming to stimulate endogenous oxytocin release through sensory nerve activation. The Marmet technique, applied for 10 minutes, follows a structured sequence of circular breast massage, downward milk movement, and manual expression techniques. The control group will receive light touch (5 minutes) applied to non-breast-related areas (wrists and shoulders) without known physiological effects on lactation or oxytocin release.

Post-intervention, mothers will perform a second round of milk expression under the same standardized conditions. Milk will not be discarded but will be fed to the infant using a spoon or syringe under researcher supervision, in accordance with neonatal nutrition safety standards.

This study is designed not only to measure lactation outcomes but also to consider maternal comfort and emotional state during the early postpartum phase, recognizing the interconnected nature of physiological milk production and maternal mental well-being. This study utilizes evidence-based lactation assessment methods and validated psychological scales. Data will be analyzed using IBM SPSS 20.0. Within-group and between-group comparisons will be conducted using paired t-tests and one-way ANOVA where appropriate. The study is approved by the relevant ethics committee and will adhere to Good Clinical Practice (GCP) guidelines.

Study Type

Interventional

Enrollment (Estimated)

123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Izmir, Turkey (Türkiye), 35030
        • Recruiting
        • Ege University Faculty of Medicine Hospital
        • Contact:
        • Principal Investigator:
          • Aysima YALÇINTEPE

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged between 18-35 years
  • Literate
  • Fluent in Turkish
  • Volunteering to participate in the study
  • Primiparous (first-time mothers)
  • Within the first 2 hours postpartum (mothers performing their first breastfeeding under researcher supervision)
  • Have a single baby with an appropriate birth weight for gestational age (>2500 gr)
  • Have their baby with them
  • Received spinal anesthesia
  • Neither the mother nor the baby has any acute or chronic illness
  • Exclusively breastfeeding their baby
  • Had a term (37 weeks gestation or more) and cesarean delivery
  • Experienced no complications after the cesarean section
  • No issues preventing breastfeeding
  • Willing to breastfeed

Exclusion Criteria:

  • Are under 18 or over 35 years old
  • Are multiparous (have given birth before)
  • Are encountered more than 2 hours postpartum
  • Received general anesthesia
  • Have any acute or chronic illness themselves or their baby
  • Have conditions requiring mother and baby to be separated
  • Report experiencing severe pain
  • Formula-feed their baby or consume any milk-increasing medication or tea
  • Gave birth before 37 weeks gestation or had a vaginal delivery
  • Have an anatomical breast issue (absence of nipple, inverted nipple)
  • Have swelling, ecchymosis, or wounds on their back (for the oxytocin massage group)
  • Have a baby with a congenital anomaly
  • Have an issue preventing breastfeeding
  • Have a psychological issue
  • Are unwilling to breastfeed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ARM1 (Marmet)

One of the traditional and natural methods mothers can use to facilitate breast milk production after childbirth is the Marmet technique.

Ensure hand hygiene and make sure the hands are warm. Ask the mother to remove her clothing/bra (assistance will be provided at this stage).

Gently stroke the breast downward toward the nipple to trigger the let-down reflex.

Starting from the armpit, move toward the breast, continuing the massage with circular finger movements around and toward the nipple.

Ask the mother to lean forward slightly to allow gravity and gentle breast shaking to create mild vibrations and facilitate milk flow and drainage.

After the procedure, assist the mother in adjusting her position assist the mother in adjusting her position and help her get dressed.

Perform hand hygiene again. This procedure will be performed for 5 minutes on each breast, totaling 10 minutes, to ensure the technique is effective and standardized according to the literature.

One of the traditional and natural efforts mothers can make to facilitate breast milk production postpartum is the Marmet technique. This technique embraces the principles of massage and stimulation of the milk ejection reflex (Widiastuti et al., 2015; Hairunisyah & Kusumawaty, 2022). Furthermore, this technique provides a relaxing effect, reactivating the milk ejection reflex, which in turn stimulates spontaneous milk flow (Yuliani et al., 2015). In other words, the Marmet technique is a combination of expressing milk and massaging the breast by emptying the lactiferous sinuses located under the areola. The Marmet technique stimulates prolactin secretion and helps maximize the milk ejection reflex. The more milk that is withdrawn or emptied from the breast, the greater the milk production (Widiastuti et al., 2015).
Other Names:
  • MarTec
Active Comparator: ARM2 (Oxct.)

Oxytocin massage is a technique applied to increase breast milk production. In this study, the following steps will be followed when performing oxytocin massage (Sari et al., 2017):

Ensure hand hygiene and make sure the hands are warm. Ask the mother to remove her clothing/bra (assistance will be provided at this stage).

Position the mother in a comfortable way (since all mothers in the oxytocin massage group will be within the first 2 hours post-cesarean, they will be positioned in bed, and if necessary, supported with pillows or rolled sheets).

Using both thumbs facing forward, apply massage from the spine to the area beside the fifth and sixth ribs in a clockwise direction, first downward then upward.

After the massage, gently wipe the mother's back with a paper towel (if she expresses discomfort).

Assist the mother in adjusting her position and help her get dressed. Perform hand hygiene again. The massage will be applied for 3 minutes.

Oxytocin massage is a type of massage performed to increase breast milk production. The massage is applied to the sides of the spine and the fifth to sixth ribs, and it stimulates the prolactin and oxytocin hormones after birth (Kosova et al., 2016). This massage serves to increase the oxytocin hormone, which can calm the mother, leading to an automatic flow of breast milk (Kilci & Sevil, 2021). Research conducted by Azizah and Ambarika (2022) shows that a combination of the Marmet technique and oxytocin massage can increase breast milk production. Massaging or stimulating the spine sends a message to the hypothalamus in the posterior pituitary by directly stimulating the medulla oblongata via neurotransmitters to release oxytocin, which then causes milk secretion from the breasts (Lestari & Linar, 2024).
Other Names:
  • OxyMas
Placebo Comparator: ARM3 (Plasebo)
A light touch will be applied to the women's wrists, elbows, and shoulders.
No intervention will be made to the participants in this group. Superficial touch will be performed on women's wrists, elbows, and shoulders.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast milk volume
Time Frame: up to 4 months
It's the amount of milk measured before and after the procedures applied to the mother.
up to 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Anxiety Scale Score
Time Frame: up to 4 months
Participants' state anxiety levels will be measured before and after the intervention using the State Anxiety Scale. The minimum possible score on the State Anxiety Scale is 20, and the maximum is 80. Higher scores indicate higher levels of anxiety.
up to 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Aysima YALÇINTEPE, Ege University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

July 3, 2025

First Submitted That Met QC Criteria

July 11, 2025

First Posted (Actual)

July 22, 2025

Study Record Updates

Last Update Posted (Actual)

September 22, 2025

Last Update Submitted That Met QC Criteria

September 16, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healhty

Clinical Trials on Marmet Technique

Subscribe